1.Investigation on Clinical Curative Effect of Yunnan Dengzhanhua Injection(Herba Erigerontis) for Cerebral Thrombosis and Its Toxicity and Side-effect on 345 Cases
Chinese Traditional Patent Medicine 1992;0(07):-
345 cases of cerebral thrombosis were treated by Yunnan Dengzhanhua Injection. 50 others,as a control group, were treated by Dansheng Injection. As a result,of Yunnan Dengzhanhua group, 98 cases were significantly effective, 199 cases were effective, 48 cases were uneffective, and both effective rate and total effective rate were 86%. Of Dansheng Injection group, the relative data were 9,16,15,28.4% and 50%,respectively. The difference between the results of two groups is very significant. (P
2.Study on alteration of IL-6 and cell immunity in patients with cerebral glioma
Yuelin ZHANG ; Shudong QIU ; Xuan LIU ; Xiaojun DANG
Journal of Xi'an Jiaotong University(Medical Sciences) 2003;0(06):-
Objective To study the content of interleukin- 6 (IL-6) and the altering pattern of erythrocyte immunity and T cell subgroup in the blood of outer circulation in the patients with cerebral glioma, and to expl ore their relationship and the clinical significance. Methods Enzyme linked immunosorbent assay (ELISA) was used to determine the content o f IL-6. The immunoabsorption was employed to examine the erythrocytic immune ac tivity and its regulatory function. Streptavidin-Peroxidase (S-P) was used to determine the cell number of CD3 (cluster of differentiation 3), CD4, CD8. Results The content of IL-6 in the group with cerebral glioma i s significantly lower than that in the control group (P0.05). Conclusion The weakening of immune function is obse rved in the patients with cerebral glioma. Testing of the content of IL-6, eryt hrocyte immunity and the activity of T subgroup has important clinical significa nce in the occurrence, development, treatment, outcome and prognosis of the cere bral glioma.